These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 5086287)

  • 1. [Discontinuous corticosteroid treatment of systemic lupus erythematosus].
    Tareeva IE
    Klin Med (Mosk); 1972 Jun; 50(6):95-9. PubMed ID: 5086287
    [No Abstract]   [Full Text] [Related]  

  • 2. Fulminant pneumonitis developed during the middle-dose corticosteroid therapy in systemic lupus erythematosus.
    Oku H; Okamura M; Amatsu K; Ohe A; Kato N; Kanayama Y; Horiguchi T; Inoue T
    Osaka City Med J; 1980; 26(2):145-9. PubMed ID: 7290651
    [No Abstract]   [Full Text] [Related]  

  • 3. [Important points in adrenal-corticosteroid therapy of systemic lupus erythematosus].
    Kashiwagi H
    Nihon Naika Gakkai Zasshi; 1990 Oct; 79(10):1371-5. PubMed ID: 2269811
    [No Abstract]   [Full Text] [Related]  

  • 4. [Blood tyrosine and the corticosteroid treatment of systemic lupus erythematosus].
    Rass IT; Borisov IA; Nikishova TA; Sura VV
    Ter Arkh; 1977; 49(8):110-5. PubMed ID: 929380
    [No Abstract]   [Full Text] [Related]  

  • 5. [Presocyl in the treatment of lupus erythematosus].
    Glavinskaia TA; Zernov VP; Ostroumova TN
    Vestn Dermatol Venerol; 1976 Jul; (7):51-3. PubMed ID: 997883
    [No Abstract]   [Full Text] [Related]  

  • 6. [Aseptic bone necrosis in systemic lupus erythematosus].
    Borisov IA; Bochman NL; Tavonius KE; Tareeva IE
    Sov Med; 1973 Nov; 36(11):103-7. PubMed ID: 4787403
    [No Abstract]   [Full Text] [Related]  

  • 7. Outcome of protein-losing gastroenteropathy in systemic lupus erythematosus treated with prednisolone and azathioprine.
    Mok CC; Ying KY; Mak A; To CH; Szeto ML
    Rheumatology (Oxford); 2006 Apr; 45(4):425-9. PubMed ID: 16234272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes of the indicators of hemostasis during corticosteroid treatment of systemic lupus erythematosus].
    Iakumova NIa; Ivanova AV; Sukhanov AA
    Vopr Revm; 1975; (1):63-5. PubMed ID: 1121805
    [No Abstract]   [Full Text] [Related]  

  • 9. Rapid appearance of severe mitral regurgitation under high-dosage corticosteroid therapy in a patient with systemic lupus erythematosus.
    Hoffman R; Lethen H; Zunker U; Schöndube FA; Maurin N; Sieberth HG
    Eur Heart J; 1994 Jan; 15(1):138-9. PubMed ID: 8174575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Physical and sexual development of girls in systemic lupus erythematosus (under massive corticosteroid therapy)].
    Borisova IuF; Riabova TV
    Vopr Okhr Materin Det; 1969 Oct; 14(10):84-5. PubMed ID: 5381156
    [No Abstract]   [Full Text] [Related]  

  • 11. [Rifampicin-induced nonresponsiveness to corticosteroid treatment in systemic lupus erythematosus: a case report].
    Itoh H; Fujihira T; Harada S; Kido M; Kajiki A; Nakashima Y; Kuroiwa A
    Kekkaku; 1984 Apr; 59(4):303-8. PubMed ID: 6748459
    [No Abstract]   [Full Text] [Related]  

  • 12. Norwegian scabies in acute SLE patient treated with high dose corticosteroid.
    Timpatanapong P; Tasanapradit P; Indulak S; Sundaravej P
    J Med Assoc Thai; 1974 Oct; 57(10):514-6. PubMed ID: 4443662
    [No Abstract]   [Full Text] [Related]  

  • 13. Correlation between steroid myopathy and serum lactic dehydrogenase in systemic lupus erythematosus.
    Kanayama Y; Shiota K; Horiguchi T; Kato N; Ohe A; Inoue T
    Arch Intern Med; 1981 Aug; 141(9):1176-9. PubMed ID: 7259378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intravenous pulsed therapy with prednisolone hemisuccinate in severe forms of systemic lupus erythematosus].
    Solakov P; Atanasov K
    Vutr Boles; 1988; 27(5):72-3. PubMed ID: 3213042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Spontaneous infrapatellar tendon rupture in a patient with systemic lupus erythematosus].
    Jakobsen LP; Knudsen TB; Bloch T
    Ugeskr Laeger; 2000 Sep; 162(38):5088-9. PubMed ID: 11014141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term clinico-dispensatory treatment of patients with systemic lupus erythematosus].
    Ivanova MM
    Vopr Revm; 1972; 12(1):26-31. PubMed ID: 5043574
    [No Abstract]   [Full Text] [Related]  

  • 17. Tuberculosis in systemic lupus erythematosus in an endemic area and the role of isoniazid prophylaxis during corticosteroid therapy.
    Mok MY; Lo Y; Chan TM; Wong WS; Lau CS
    J Rheumatol; 2005 Apr; 32(4):609-15. PubMed ID: 15801014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posterior subcapsular cataracts. Related to long-term corticosteroid treatment in children.
    Bihari M; Grossman BJ
    Am J Dis Child; 1968 Dec; 116(6):604-8. PubMed ID: 5697192
    [No Abstract]   [Full Text] [Related]  

  • 19. [Fluctuation of serum complement activities in systemic lupus erythematosus and its clinical significance].
    Okuda M
    Naika; 1970 Feb; 25(2):353-8. PubMed ID: 5309587
    [No Abstract]   [Full Text] [Related]  

  • 20. [The long-term parenteral use of cyclophosphane in treating patients with systemic lupus erythematosus and central nervous system involvement].
    Ivanova MM; Bliziuk OI; Travkina IV
    Ter Arkh; 1995; 67(5):45-7. PubMed ID: 7638778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.